High Signal Resolution Pulse Oximetry as a Prognostic Indicator of Radiotherapy Toxicity: A Pilot Study

Abstract

<b><i>Introduction:</i></b> Radiotherapy plays a prominent role in the multidisciplinary treatment of cancers. Despite new irradiation techniques, radiation-induced cardiotoxicity remains a leading cause of morbidity and mortality. Therefore, prognostic indicators of radiotherapy toxicity are essential. This study aimed to investigate the influence of applied radiotherapy on the pulse wave recording and thereby on cardiovascular health, as well as to assess whether high signal resolution (HSR) pulse oximetry could be used as a prognostic indicator of radiotherapy toxicity. <b><i>Methods:</i></b> A total of 19 patients treated with radiotherapy to the lung or left breast were analyzed. Pulse oximetry was performed on all eligible patients (before and after the administration of a radiation dose) using the PULS-HSR program, which increases the resolution of the pulse wave recording. <b><i>Results:</i></b> Among the analyzed variables, we found the total dose administered to the target, as well as the treatment duration, significantly positively correlated with the change in ventricle/aorta volume ratio. The ventricle/aorta volume ratio parameter is the ratio between the area under the HSR pulse wave generated by the contraction of the left ventricle until the aortic valve closes and the area of the HSR pulse wave responsible for expansion and contraction of the aorta. <b><i>Conclusion:</i></b> The pilot study indicates HSR pulse oximetry, especially the ventricle/aorta volume ratio parameter, as a potential prognostic indicator of toxicity from radiation for breast and lung cancers.